Lista de obras -

Circulating Soluble Fas and Fas Ligand Levels Are Elevated in Children with Nonalcoholic Steatohepatitis

artículo científico publicado en 2015

Clinical Research in Hepatology in the COVID-19 Pandemic and Post-Pandemic Era: Challenges and the Need for Innovation

artículo científico publicado en 2020

Combination therapies including cilofexor and firsocostat for bridging fibrosis and cirrhosis due to NASH

scientific article published on 10 November 2020

Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease.

artículo científico publicado en 2012

Designing Clinical Trials in Pediatric Nonalcoholic Steatohepatitis: Tips for Patient Selection and Appropriate Endpoints

scientific article published on 08 November 2019

Development and validation of a new histological score for pediatric non-alcoholic fatty liver disease

artículo científico publicado en 2012

Hepatic fibrosis associates with multiple cardiometabolic disease risk factors: The Framingham Heart Study

scientific article published on 30 October 2020

Looking Into the Crystal Ball: Predicting the Future Challenges of Fibrotic NASH Treatment

artículo científico publicado en 2019

MRI-PDFF treatment response criteria in nonalcoholic steatohepatitis

artículo científico publicado en 2020

Maintaining Patient Safety and Data Integrity of NASH Clinical Trials During the SARS-CoV-2 Pandemic

artículo científico publicado en 2020

Nonalcoholic fatty liver disease: Reporting histologic findings in clinical practice

artículo científico publicado en 2020

Nonalcoholic fatty liver disease: a challenge for pediatricians.

artículo científico publicado en 2015

Noninvasive Testing Using Magnetic Resonance Imaging Techniques as Outcomes in Nonalcoholic Steatohepatitis Clinical Trials: How Full Is the Glass?

scientific article published on 03 February 2020

Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials

artículo científico publicado en 2019

Reduced lysosomal acid lipase activity - A potential role in the pathogenesis of non alcoholic fatty liver disease in pediatric patients

artículo científico publicado en 2016

Retinol-binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease.

artículo científico publicado en 2009

Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosis

scientific article published on 30 August 2018

Serum cytokeratin-18 fragment levels are useful biomarkers for nonalcoholic steatohepatitis in children.

artículo científico publicado en 2013

The Commensal Microbe Veillonella as a Marker for Response to an FGF19 Analog in Nonalcoholic Steatohepatitis

artículo científico publicado en 2020

Lista de obras de

Circulating Soluble Fas and Fas Ligand Levels Are Elevated in Children with Nonalcoholic Steatohepatitis

Clinical Research in Hepatology in the COVID-19 Pandemic and Post-Pandemic Era: Challenges and the Need for Innovation

Combination therapies including cilofexor and firsocostat for bridging fibrosis and cirrhosis due to NASH

Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease.

Designing Clinical Trials in Pediatric Nonalcoholic Steatohepatitis: Tips for Patient Selection and Appropriate Endpoints

Development and validation of a new histological score for pediatric non-alcoholic fatty liver disease

Hepatic fibrosis associates with multiple cardiometabolic disease risk factors: The Framingham Heart Study

Looking Into the Crystal Ball: Predicting the Future Challenges of Fibrotic NASH Treatment

MRI-PDFF treatment response criteria in nonalcoholic steatohepatitis

Maintaining Patient Safety and Data Integrity of NASH Clinical Trials During the SARS-CoV-2 Pandemic

Nonalcoholic fatty liver disease: Reporting histologic findings in clinical practice

Nonalcoholic fatty liver disease: a challenge for pediatricians.

Noninvasive Testing Using Magnetic Resonance Imaging Techniques as Outcomes in Nonalcoholic Steatohepatitis Clinical Trials: How Full Is the Glass?

Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials

Reduced lysosomal acid lipase activity - A potential role in the pathogenesis of non alcoholic fatty liver disease in pediatric patients

Retinol-binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease.

Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels predict the presence of fibrotic nonalcoholic steatohepatitis (NASH) and NASH cirrhosis

Serum cytokeratin-18 fragment levels are useful biomarkers for nonalcoholic steatohepatitis in children.

The Commensal Microbe Veillonella as a Marker for Response to an FGF19 Analog in Nonalcoholic Steatohepatitis